Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Sonographic fatty liver, overweight and ischemic heart disease
2005
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Nonalcoholic fatty liver disease
2004
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism
2017
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
2010 Standout
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
2010 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Atorvastatin and Antioxidants for the Treatment of Nonalcoholic Fatty Liver Disease: The St Francis Heart Study Randomized Clinical Trial
2010
Confounding factors of non-invasive tests for nonalcoholic fatty liver disease
2020
Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment
2004
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Recent concepts in non‐alcoholic fatty liver disease
2005
Pathogenesis and management issues for non-alcoholic fatty liver disease
2007
Prevalence and associated factors of non‐alcoholic fatty liver disease in patients with type‐2 diabetes mellitus
2008
Diversity and Function of Mutations in P450 Oxidoreductase in Patients with Antley-Bixler Syndrome and Disordered Steroidogenesis
2005
Liver fibrosis
2005 Standout
NASH Predicts Plasma Inflammatory Biomarkers Independently of Visceral Fat in Men
2008
The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease
2004
The Prevalence of Metabolic Syndrome In Non-alcoholic Fatty Liver Disease; A Population-Based Study
2016
Light and Moderate Alcohol Consumption Significantly Reduces the Prevalence of Fatty Liver in the Japanese Male Population
2009
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol
2016
Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver
2016
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
2010 Standout
Hepatic steatosis in obese patients: clinical aspects and prognostic significance
2004
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy
2014
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
2008 Standout
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Development of new fatty liver, or resolution of existing fatty liver, over five years of follow-up, and risk of incident hypertension
2014
Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease
2005 Standout
Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study
2006
Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan
2006
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
2015
Multimorbidity and polypharmacy in diabetic patients with NAFLD
2017
Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications
2009 Standout
Non‐alcoholic fatty liver disease: An overview
2002
The NAFLD fibrosis score
2007 Standout
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Diabetic Retinopathy
2012 Standout
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
2018
The metabolic syndrome
2005 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Non-alcoholic fatty liver disease
2021 Standout
Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain
2009
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography
2011
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #
2005
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
2006 Standout
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Estimation of the Healthy Upper Limits for Serum Alanine Aminotransferase in Asian Populations With Normal Liver Histology
2009
Non-alcoholic fatty liver disease and liver transplantation
2016
Magnetic resonance imaging and spectroscopy for monitoring liver steatosis
2008
Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: A review of 589 consecutive liver biopsies in a single center
2007
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease
2006
Non‐alcoholic fatty liver disease – a common and benign finding in octogenarian patients
2004
Donor evaluation and hepatectomy for living-donor liver transplantation
2008
NAFLD in Asia—as common and important as in the West
2013
Noninvasive Differentiation of Simple Steatosis and Steatohepatitis by Using Gadoxetic Acid–enhanced MR Imaging in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study
2014
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease
2008
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study
2006
Nonalcoholic fatty liver disease
2005 Standout
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
2011 Standout
Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
2008
In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
2012
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
2013
Clinical trial: insulin‐sensitizing agents may reduce consequences of insulin resistance in individuals with non‐alcoholic steatohepatitis
2008
Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis
2004
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Epidemiology and Natural History of NAFLD and NASH
2007
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
2006
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
2009
Hepatocellular Carcinoma
2011 Standout
Diagnosis of fatty liver disease
2003
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients
2010
Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy
2011
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
2003
Eicosapentaenoic acid ameliorates steatohepatitis and hepatocellular carcinoma in hepatocyte-specific Pten-deficient mice
2008 StandoutNobel
Prevalence and risk factors for non‐alcoholic fatty liver disease among adults in an urban Sri Lankan population
2009
Noninvasive assessment of fibrosis and steatosis in NASH and ASH
2009
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Heritability of non‐alcoholic fatty liver disease and association with abnormal vascular parameters: A twin study
2012
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Evaluation of Liver Fibrosis: A Concise Review
2004
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Influence of non‐alcoholic fatty liver disease on the development of diabetes mellitus
2012
A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease
2015
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease
2016
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
2010
Hepatic Steatosis, Obesity, and the Metabolic Syndrome Are Independently and Additively Associated With Increased Systemic Inflammation
2011
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
2013
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
2005
Nonalcoholic Fatty Liver Disease Is Associated With Carotid Atherosclerosis
2005
Prevalence of Nonalcoholic Fatty Liver Disease and Its Association With Cardiovascular Disease Among Type 2 Diabetic Patients
2007
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Noninvasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2016
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Nonalcoholic Fatty Liver Disease Is Independently Associated With an Increased Incidence of Cardiovascular Events in Type 2 Diabetic Patients
2007
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease
2007
Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease
2015
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
The Metabolic Syndrome
2008 Standout
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan: Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese Adults
2006
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
2015
Prevalence and determinants of fatty liver in normal-weight and overweight young adults. The Cardiovascular Risk in Young Finns Study
2014
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients
2005
Nonalcoholic Fatty Liver Disease
2015 Standout
Works of M Hurley being referenced
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
Antley-Bixler syndrome with radioulnar synostosis
2004